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The objective of this study was to investigate the formation and synthetic mechanism of related 
substance G in potassium clavulanate production. The impurity in the potassium clavulanate final 
product, with a retention time of 13.5 min, was confirmed as related substance G by high performance 
liquid chromatography-mass spectrometry/mass spectrometry. Related substance G analysis during 
the production of clavulanic acid showed that this impurity could be synthesized during fermentation, 
and the amount increased with the fermentation time. Studies on its synthetic mechanism showed that 
L-tyrosine and succinic acid were the precursors for biosynthesis of related substance G in vivo. The 
reaction was deduced to be catalyzed by an enzyme. The enzyme was a type of extracellular enzyme 
present in the fermentation supernatant.
Uniterms: Potassium clavulanate/production. Clavulanic acid/production. Related substance G./structure 
identification. Related substance G./synthetic mechanism. High Performance Liquid Chromatography-
Mass Spectrometry-Mass Spectrometry/analysis
O objetivo deste estudo foi investigar a formação e o mecanismo sintético da substância G relacionada 
na produção de clavulanato de potássio. A impureza do produto final clavulanato de potássio, com tempo 
de retenção de 13,5 min, foi confirmada como substância G relacionada por cromatografia líquida de alta 
eficiência-espectrometria de massas/espectrometria de massas. A análise da substância G relacionada 
durante a produção do ácido clavulânico mostrou que essa impureza poderia ser sintetizada durante 
a fermentação e que a quantidade aumenta com o tempo de fermentação. Estudos do seu mecanismo 
sintético mostraram que a L-tirosina e o ácido succínico foram os precursores in vivo para a biossíntese 
da substância G relacionada. Deduziu-se que a reação foi catalisada por uma enzima. A enzima foi do 
tipo extracelular, presente no sobrenadante da fermentação.
Unitermos: Clavulanato de potássio/produção. Ácido clavulânico/produção. Substância G relacionada/
identificação estrutural. Substância G relacionada/mecanismo sintético. Cromatografia Líquida de Alta 
Eficiência-Espectrometria de massas-Espectrometria de massas/análise
INTRODUCTION
As the emergence of antibiotic resistant organisms 
threatens to return treatment of infectious diseases to 
a pre-antibiotic era, strategies aimed at overcoming 
acquired resistance are of increasing interest. One of 
the best examples of wide clinical application of this 
strategy is the development of β-lactamase inhibitors 
for use in combination with conventional β-lactam 
antibiotics. Commercial products such as AugmentinTM 
and TimentinTM, combinations of clavulanic acid together 
with amoxicillin or ticarcillin, respectively, have made 
clavulanic acid a valued product in excess of a billion 
dollars/annum (Aharonowitz, Demain, 1978; Parag, 
Shrikant, Rekha, 2008). Clavulanic acid, a type of 
lactamase inhibitor, is a secondary metabolite produced 
X. Jin, G. Cao, X. Zhang, Y. Chen, L. Wang, C. Zhong78
by Streptomyces clavuligerus (Saudagar, Singhal, 
2007; Shetty et al., 2010). Potassium clavulanate is the 
most widely used pharmaceutically acceptable form 
of clavulanic acid. Usually, potassium clavulanate is 
produced by industrial fermentation, including three main 
processes: fermentation, filtration and extraction and 
crystallization to obtain the crude product, tert-butylamine 
clavulanate, and polishing to obtain the final product, 
potassium clavulanate. It is difficult to obtain a high quality 
product because of the chemical instability of clavulanic 
acid. Clavulanic acid is degraded rapidly into complexes 
including multiple components (Parag, Shrikant, 
Rekha, 2008; Sunderland, Vahdat, 2009). Seven related 
substances (designated A-G, respectively) have been 
found in potassium clavulanate as noted in the European 
Pharmacopoeia. Among these, related substances A, B, C, 
D and F are synthesized by the catabolism of clavulanic 
acid under acid or alkali conditions (Finn et al., 1984; 
Haginaka et al., 1985). Related substance E is synthesized 
by the combination of the amino group of one molecule 
of clavulanic acid with the carboxyl group of another 
molecule of clavulanic acid with the opening of the 
β-lactam ring (Zhong et al., 2014).
Related substance G is one of the main impurities 
in commercially available potassium clavulanate, and it 
directly affects the quality of the final product (Zhong, Cao, 
Chen, 2008). So far, there has been little relevant research 
on related substance G and its mechanism of synthesis. 
In this study, an impurity in potassium clavulanate with 
a retention time of 13.5 min was confirmed to be related 
substance G by high performance liquid chromatography-
mass spectrometry/mass spectrometry (HPLC-MS/MS), 
and the synthetic mechanism of related substance G was 
investigated. It would be useful to reduce the content of 
related substance G to improve the quality of potassium 
clavulanate.
MATERIAL AND METHODS
Microbial strains
The industrial production strain was Streptomyces 
clavuligerus F613-1.
Reagents
Ammonium formate, formic acid and methanol 
were LC grade. Ultra-pure water used for the preparation 
of running buffers and standard solutions was obtained 
from a Milli-Q system. All other reagents, such as acetone, 
isopropyl alcohol, ethanol, acetic acid, sodium hydroxide, 
L-tyrosine, succinic acid, sodium alginate and calcium 
chloride were of analytical reagent grade.
Standard and preparations
Lithium clavulanate standard, tert-butylamine 
clavulanate (crude product), potassium clavulanate 
(final product) and industrial fermentation medium were 
provided by Lunan Pharmaceutical Co., Ltd. (Shandong, 
China). The contents of clavulanic acid in the lithium 
clavulanate standard, tert-butylamine clavulanate and 
potassium clavulanate were 96.0%, 66.5% and 83.6%, 
respectively.
Instrumental parameters
An Agilent 1100 HPLC system and Agilent 1200-
6410 LC-MS/MS were used to determine the content 
and structure of related substance G. A Mettler AL104 
electronic analytical balance were used to weigh the 
sample. A shaking bed was used in the experiment to 
determine the synthetic mechanism.
HPLC analysis conditions
We used the method described in the European 
Pharmacopoeia (2010) to determine clavulanic acid and 
related substance G. The content of related substance G 
was calculated by the main component self-contrasted 
method. One milliliter of the test solution was diluted to 
100.0 mL with mobile phase A as the reference solution. 
The content of related substance G was the ratio of the 
peak area of related substance G in the test solution to 
the peak area of clavulanic acid in the reference solution. 
The HPLC details were as follows: mobile phase A was 
0.03 mol L-1 ammonium formate solution (pH 4), and 
mobile phase B was an equivalent mixture of methanol 
and mobile phase A. The elution gradient was 0-4 min 
mobile phase A 100%, 4-15 min mobile B 0-50%, 15-18 
min mobile B 50-0%, 18-30 min mobile A 100% at a flow 
rate of 1 mL min-1. The temperature inside the column was 
maintained at 40°C. Detection was carried out at 230 nm. 
The injection volume was 20 µL. Samples were well 
separated on an Inertsil ODS-3 chromatographic column 
(4.6 mm × 150 mm, 5 µm).
HPLC-MS/MS analysis conditions
HPLC analysis conditions were as described above 
with post-column split, electrospray ionization, negative 
ion detection and MS2 scans. The collision energy was 5 V.
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Related substance G analysis during the 
production of clavulanic acid
The production process of potassium clavulanate 
includes three main processes: fermentation, filtration and 
extraction, and crystallization to obtain the crude product, 
tert-butylamine clavulanate, and polishing to obtain the 
final product, potassium clavulanate. We sampled the 
fermentation broth, crude product and finished product 
to analyze the stage at which related substance G was 
generated. We also needed to determine whether related 
substance G could be generated during the fermentation 
process. Thus, the blank medium (sterilized) and the 
fermentation liquids from different time points (24 h, 
48 h, 72 h and 96 h, respectively) during the fermentation 
process were sampled. All the samples were treated with 
the following methods according to their characteristics, 
and the contents of clavulanic acid and related substance 
G were determined by HPLC.
Fermentation liquid samples were processed as 
follows: precisely 5 g of fermentation liquid was weighed 
and the sample was diluted to 25 mL with mobile phase 
A. The aqueous phase was collected after centrifugation 
(at a speed of 7100 g for 4 min) and filtered (through a 
0.22 mm membrane).
The solid samples were processed as follows: 
precisely 0.25 g was weighed and diluted to 25 mL with 
mobile phase A.
Verification on the biosynthesis precursors of 
related substance G
The final fermentation broth at 96 h was chosen as 
the experimental material. Sterilized shaker flasks with the 
same fermentation broth were divided into four groups, and 
then L-tyrosine alone, succinic acid alone, and L-tyrosine 
and succinic acid together (1:1,w/w) were added to three 
groups to a final concentration of 1 g L-1. The fourth group 
was the control group. All four groups were cultivated on a 
shaking table at 28 °C with a rotation speed of 50 rpm for 
72 h. Samples at different time points (0 h, 24 h, 48 h and 
72 h) were analyzed for related substance G.
Study of the biosynthetic mechanism of related 
substance G
The fermentation broth was centrifuged at 3800 g 
for 30 min, and the supernatant was filtered through a 0.22 
µm aseptic filter, and the fresh cells were washed with 0.1 
M aseptic Tris-HCl buffer (pH 7.0). The supernatant, fresh 
cells and purified water (as the control) were prepared 
as follows: samples were mixed with 20 g L-1 sterilized 
sodium alginate solution in a proportion of 1:1, and then 
the mixtures were dropped slowly into 20 g L-1 sterilized 
calcium chloride solution by a sterile syringe. Solid balls 
then appeared; the balls were washed with 0.1 M aseptic 
Tris-HCl buffer (pH 7.0) until the washed buffer was 
colorless. The balls were mixed with 0.1 M aseptic Tris-
HCl buffer (pH7.0), then L-tyrosine and succinic acid were 
added to achieve a final concentration 1 g L-1. The samples 
were then cultivated with ampicillin (100 µg mL-1) on a 
shaking bed at 28 °C with a rotation speed 50 rpm for 72 h. 
Samples at different time points (0 h, 24 h, 48 h and 72 h) 
were analyzed for related substance G.
RESULTS AND DISCUSSION
Structural identification of the impurity at 
13.5 min
An impurity appears at a retention time of 13.5 
min in some final products of potassium clavulanate. The 
maximum content of the impurity may reach 0.5% (w/w). 
HPLC analysis showed that the impurity was a single 
substance and the retention time was similar to that of 
related substance G, as noted in the section in potassium 
clavulanate in the European Pharmacopoeia (2010). We 
speculated that the impurity was related substance G. The 
chemical structure of related substance G, provided by the 
European Pharmacopoeia, is shown in Figure 1.
HPLC is a valid method for the determination of free 
arginine, glutamine and β-alanine in nutritional products 
and dietary supplements (Jeffrey, Paul, 2012). HPLC-MS/
MS is also a method to analyze tebuconazole, tetraconazole 
enantiomers and plant growth regulators (Ma et al., 2013; 
Zhang et al., 2012). Tandem mass spectrometry analysis 
was executed by HPLC-MS/MS in order to define its exact 
chemical structure. HPLC-MS/MS was used to determine 
whether the impurity with a retention time of 13.5 min 
in the final product (potassium clavulanate) was related 
substance G. First-order and secondary mass spectrograms 
FIGURE 1 - Chemical structure of related substance G from the 
European Pharmacopoeia (2010).
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are shown in Figure 2a and Figure 2b, respectively. The 
results of the mass spectrometry show that the molecular 
ion mass-to-charge ratio was m/z 280, and the molecular 
mass was the same as that of related substance G in 
European Pharmacopoeia. All these data show that the 
impurity was related substance G.
Tandem mass spectrometry analysis showed that 
the molecular ion with m/z 280 could be dissociated 
into fragments such as m/z 262, m/z 180 and m/z 98. 
Combining the characteristics of fragment ions, relative 
abundance, the general rule of ion fragmentation, and the 
chemical structure of related substance G, we speculated 
on the possible fragmentation path of the molecular ion 
with m/z 280 (Figure 3).
Analysis of the producing stage of related 
substance G
Samples from different production stages were 
analyzed for clavulanic acid and related substance G by 
HPLC, including the blank culture medium, fermentation 
broth, crude product and the finished product. The results 
are shown in Figure 4. Neither clavulanic acid nor related 
substance G were found in the blank culture medium, 
while in the final fermentation broth, the relative content of 
related substance G to clavulanic acid reached 2.22%. The 
relative content of related substance G decreased to 0.17% 
and 0.03% in the crude product and finished product, 
respectively. Related substance G was thus generated 
during fermentation and not in downstream processes.
The changes in the content of related substance G 
during the fermentation process were studied in order 
to analyze the possible synthesis pathway of related 
substance G. The content of related substance G at the 
time points of 0 h, 24 h, 48 h, 72 h and 96 h during the 
fermentation process are shown in Figure 5. There was 
neither related substance G nor clavulanic acid in the 
sterilized blank medium. About 0.3 g L-1 clavulanic acid 
was detected at 24 h, and 0.004 g L-1 of related substance 
G was detected. The concentration of the clavulanic acid 
reached 2.07 g L-1 at 48 h, when related substance G was 
0.026 g L-1, so the average biosynthesis rate of related 
substance G was 0.0009 g L-1·h-1. Thereafter, clavulanic 
acid and related substance G increased simultaneously. 
At 72 h, related substance G reached 0.07 g L-1, and 
the average biosynthesis rate increased gradually, up to 
0.0018 g L-1·h-1. In the final fermentation broth, clavulanic 
FIGURE 2 - Mass spectra of the substance with a retention time 
of 13.5 min. (a) First order mass spectrum; (b) Secondary mass 
spectrum.
FIGURE 3 - Possible fragmentation path of related substance G
FIGURE 4 - The relative percentage amount of related substance 
G during the production process. A: blank culture medium; B: 
final fermentation broth; C: crude product; D: final product.
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FIGURE 5 – The content of clavulanic acid and related substance 
G during the fermentation process. A: clavulanic acid, B: related 
substance G; 1: sterilized blank medium (0 h); 2: Early stage of 
fermentation (24 h); 3: medium stage of fermentation (48 h); 4: 
later stage of fermentation (72 h); 5: final stage of fermentation 
(96 h).
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FIGURE 6 - The content of related substance G in the 
fermentation broth with the addition of different precursors. 
■: L-tyrosine alone, ○: succinic acid alone, ▲: L-tyrosine and 
succinic acid together, ☆: nothing added (control group).
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acid reached 4.87 g L-1, and related substance G reached 
0.108 g L-1, but the average biosynthesis rate of related 
substance G decreased slightly to 0.0016 g L-1·h-1. From 
the results presented here, it can be concluded that related 
substance G was generated during the middle and later 
periods of fermentation, and its content increased with 
fermentation time. However, the average biosynthesis rate 
decreased slightly during the later period of fermentation.
 
Verification of the biosynthesis precursors of 
related substance G
Related substance G is called N-succinyltyrosine 
in EP7.0 (European Pharmacopoeia Commission of the 
Council of Europe, 2010) and it has been synthesized by 
chemical methods from L-tyrosine and succinic acid as 
the raw materials (Chen et al., 2013). However, whether 
related substance G is synthesized from L-tyrosine and 
succinic acid in vivo has not been reported. The final 
fermentation broth at 96 h was chosen as the experiment 
material. L-tyrosine alone, succinic acid alone, and 
L-tyrosine and succinic acid together (1:1, w/w) were 
added and then cultivated for 72 h, with sampling at 0 h, 
24 h, 48 h and 72 h for the content of related substance 
G. The data are shown in Figure 6. The content of related 
substance G increased in all four groups over time, but the 
group with L-tyrosine and succinic acid added together had 
a much higher level than the control group. The content of 
related substance G in the control group was 0.111 g L-1 
at 72 h and increased by 11.1%. The amount of related 
substance G in the group with L-tyrosine alone increased 
by 12.9% at 72 h, reaching 0.114 g L-1. The amount of 
related substance G in the group with succinic acid alone 
increased by 11.9% at 72 h, reaching 0.113 g L-1. The 
amount of related substance G in the group with L-tyrosine 
and succinic acid together increased by 20.79% at 72 h, 
reaching 0.122 g L-1; this was significantly higher than the 
level in the control group.
The content of related substance G increased in 
the control group because there were some L-tyrosine 
and succinic acid in the final fermentation broth. Over 
time, L-tyrosine and succinic acid were consumed, so 
the biosynthesis of related substance G slowed gradually 
and almost stopped in the control group after 48 h. The 
amount of related substance G increased slightly in the 
groups with L-tyrosine alone and succinic acid alone, 
because there were also insufficient precursors. There 
were sufficient precursors in the group with L-tyrosine 
and succinic acid added together, so the amount of related 
substance G increased and was significantly higher than in 
the control group at 72 h. From the results presented here, 
it can be concluded that L-tyrosine and succinic acid are 
the precursors for the biosynthesis of related substance 
G in vivo.
Study of the biosynthetic mechanism of related 
substance G
Related substance G can be synthesized by 
chemical synthesis with L-tyrosine and succinic acid 
as the raw materials (Chen et al., 2013), and can also 
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be generated by S. clavuligerus, but the synthetic 
mechanism of related substance G in vivo has not been 
reported. In this study, we immobilized the supernatant 
and cells using alginate, and these were cultivated 
after adding L-tyrosine and succinic acid together as 
precursors. The content of related substance G is shown 
in Figure 7. The data show that related substance G could 
be detected in the supernatant after immobilization, and 
the content increased over time, reaching 0.069 g L-1 
at 72 h. The content of related substance G in the cells 
after immobilization was small, and the level in the 
control group was zero. From these results, extracellular 
enzymes present in the supernatant may catalyze the 
biosynthesis of related substance G.
The carboxyl group of succinic acid and the amino 
group of L-tyrosine form the amide bond in the related 
substance G molecule. The biosynthesis is perhaps 
similar to enzyme-catalyzed amide bond synthesis. 
First, the carboxyl group of succinic acid is activated by 
phosphorylation or acylation, and is then attacked by the 
amino group of L-tyrosine to form the amide bond. The 
reaction can be catalyzed by specific enzymes such as 
amide synthetase, or by enzymes for non-peptide amide 
bond formation (Bordusa, 2000; Maruyama et al., 2012; 
Ladkau et al., 2011). In addition, proteases as catalysts are 
capable of accelerating the hydrolysis of peptide bonds in 
aqueous solution, as well as the synthesis of peptide bonds 
and non-peptide amide bonds in a small hydrophobic zone 
(Stepanov, 1996; Chen et al., 2010). So, proteases may 
be the enzymes required for the biosynthesis of related 
substance G. The detailed biosynthetic mechanism of 
related substance G and the related enzymes are areas of 
research focus in the future.
CONCLUSIONS
HPLC-MS/MS analysis verified that the impurity 
with a retention time of 13.5 min is related substance G, 
as noted in European Pharmacopoeia (2010). Related 
substance G was formed during fermentation, and 
increased with fermentation time.
Studies on its synthetic mechanism showed that 
L-tyrosine and succinic acid were the precursors for 
the biosynthesis of related substance G in vivo, and the 
reaction was deduced to be catalyzed by an enzyme. 
The enzyme was an extracellular enzyme present in the 
fermentation supernatant.
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